Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000212434

Medchemexpress LLC 2-[2-(5-bromo-1H-indol-3-yl)ethyl]-3-[3-(1-methylethoxy)phenyl]-4-(3H)-quinazoline | 133040-77-4 | MFCD00907856 | 98.9% | 502.40 g/mol | C27H24BrN3O2 | 25 MG
SDP

Supplier:  Medchemexpress LLC HY10135225MG

Encompass_Preferred

LY 225910 is a selective antagonist of the cholecystokinin type 2 receptor (CCK2) used as a research tool to study CCK2-mediated signaling, opioid interactions such as morphine sensitization, and related pharmacology. Supplied as a solid research chemical, it is characterized by a brominated indole-quinazoline structure and analytical purity suitable for biochemical and in vivo assays.

  • Selective CCK2 receptor antagonist suitable for pharmacological studies.
  • High purity for research applications (≈98.9%).
  • Solid, white to off-white form for convenient handling and storage.
  • Stable under recommended storage conditions for prolonged shelf life.
  • Brominated indole-quinazoline scaffold supports receptor binding.

Catalog No. 50-002-12434


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.